Pharmacotherapy of lower urinary tract infections and pyelonephritis in children

Bibliography

• Abrahamsson K, Hansson S, Larsson P, Jodal U. Antibiotic treatment for five days is effective in children with acute cystitis. Acta Paediatr 2002;91:55-8
   PubMedGoogle Scholar
• Bloomfield P, Hodson EM, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev 2005;1:CD003772
   Google Scholar
• Agence Francaise de Securité Sanitaire des Produits de Santé. Diagnostique et antibiothérapie des infections urinaires bactériennes communautaires du nourrisson et de l'enfant. Paris: AFSSAPS, 2007
   Google Scholar
• Bouissou F, Munzer C, Decramer S, et al. Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months. Pediatrics 2008;121:e553-60
   PubMed Web of Science ®Google Scholar
• Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999;104:79-86
   PubMed Web of Science ®Google Scholar
• Montini G, Toffolo A, Zucchetta P, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ 2007;335:386
   PubMed Web of Science ®Google Scholar
• Mak RH, Wong JH. Are oral antibiotics alone efficacious for the treatment of a first episode of acute pyelonephritis in children? Nat Clin Pract Nephrol 2008;4:10-1
   PubMedGoogle Scholar
• Prelog M, Schiefecker D, Fille M, et al. Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatr Nephrol 2008;23:597-602
   PubMedGoogle Scholar
• National Institute for Health and Clinical Excellence. Urinary tract infection in children, 2007. Available from: http://guidance.nice.org.uk/CG054
   Google Scholar
• Downs SM. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999;103:e54
   Google Scholar
• Seidel T, Kuwertz-Broking E, Kaczmarek S, et al. Acute focal bacterial nephritis in 25 children. Pediatr Nephrol 2007;22:1897-901
   PubMed Web of Science ®Google Scholar
• Michael M, Hodson EM, Craig JC, et al. Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child 2002;87:118-23
   PubMed Web of Science ®Google Scholar
• Cheng CH, Tsau YK, Lin TY. Effective duration of antimicrobial therapy for the treatment of acute lobar nephronia. Pediatrics 2006;117:e84-9
   Web of Science ®Google Scholar
• Frimodt-Moller N. Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Antimicrob Agents 2002;19:546-53
   PubMed Web of Science ®Google Scholar
• Bradley JS, Dudley MN, Drusano GL. Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulation. Pediatr Infect Dis J 2003;22:982-92;quiz 993-985
   PubMed Web of Science ®Google Scholar
• Garin EH, Olavarria F, Garcia Nieto V, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006;117:626-32
   PubMed Web of Science ®Google Scholar
• Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008;179:674-9; discussion 679
   PubMed Web of Science ®Google Scholar
• Conway PH, Cnaan A, Zaoutis T, et al. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007;298:179-86
   PubMed Web of Science ®Google Scholar
• Olbing H, Smellie JM, Jodal U, Lax H. New renal scars in children with severe VUR: a 10-year study of randomized treatment. Pediatr Nephrol 2003;18:1128-31
   PubMed Web of Science ®Google Scholar
• Smellie JM, Jodal U, Lax H, et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. J Pediatr 2001;139:656-63
   PubMedGoogle Scholar
• Bensman A, Ulinski T. International Vesicoureteral Reflux Study: unsolved questions remaining. Pediatr Nephrol 2006;21:757-8
   PubMed Web of Science ®Google Scholar
• Jodal U, Smellie JM, Lax H, Hoyer PF. Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol 2006;21:785-92
   PubMed Web of Science ®Google Scholar
• Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin to reduce the number of unnecessary cystographies in children with a urinary tract infection: a European validation study. J Pediatr 2007;150:89-95
   PubMedGoogle Scholar
• Hajibagheri K, Priesemann M, Morrison I, et al. NICE guidance on urinary tract infection in children abandons routine antibiotic prophylaxis. Arch Dis Child 2008;93356
   PubMedGoogle Scholar
• Marks SD, Gordon I, Tullus K. Imaging in childhood urinary tract infections: time to reduce investigations. Pediatr Nephrol 2008;23:9-17
   PubMedGoogle Scholar
• Ginsburg CM, McCracken GH Jr. Urinary tract infections in young infants. Pediatrics 1982;69409-12
   PubMed Web of Science ®Google Scholar
• Wiswell TE, Smith FR, Bass JW. Decreased incidence of urinary tract infections in circumcised male infants. Pediatrics 1985;75:901-3
   PubMed Web of Science ®Google Scholar
• Wiswell TE, Roscelli JD. Corroborative evidence for the decreased incidence of urinary tract infections in circumcised male infants. Pediatrics 1986;78:96-9
   PubMed Web of Science ®Google Scholar
• Godaly G, Svanborg C. Urinary tract infections revisited. Kidney Int 2007;71:721-3
   PubMed Web of Science ®Google Scholar
• Svanborg C, Godaly G, Hedlund M. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol 1999;2:99-105
   PubMed Web of Science ®Google Scholar
• Godaly G, Otto G, Burdick MD, et al. Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. Kidney Int 2007;71:778-86
   PubMed Web of Science ®Google Scholar
• Tseng CC, Huang JJ, Wang MC, et al. PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int 2007;71;764-70
   PubMedGoogle Scholar
• Diard S, Liévin-Le Moal V, et al. Norepinephrine-dependently released Dr fimbriae of diffusely adhering Escherichiacoli strain IH11128 promotes a mitogen-activated protein kinase ERK1/2-dependent production of pro-inflammatory cytokine, IL-8 in human intestinal Caco-2/TC7cells. Microbes Infect 2009. In press
   PubMedGoogle Scholar
• Ashkar AA, Mossman KL, Coombes BK, et al. FimH adhesin of type1 fimbriae is a potent inducer of innate antimicrobial responses which requiresTLR4 and type 1 interferon signalling. PLoS Pathog 2008 Dec;4(12):e1000233
   PubMed Web of Science ®Google Scholar